Please login to the form below

Not currently logged in
Email:
Password:

Jeffrey Gold appointed CEO of myoscience

Previously worked as president and COO at the firm
Jeffrey Gold

Jeffrey Gold has been named as CEO of medical device company myoscience.

Gold has previously held the positions of president and chief operating officer at the company. Previously he has held posts as chief executive for Velomedix and CryoVascular Systems as well as being chief operating officer for CardioThoracic Systems.

Concerning his appointment, Gold commented: “I am very excited to assume the responsibility of guiding myoscience through its next development stage. The myoscience tea has built an extremely strong platform technology that targets two distinct markets, aesthetics and peripheral nerve pain.

“We have a strong team of dedicated professionals that will drive myoscience to greater success in the future.”

Prior to his roles at Velomedix, Gold was a venture partner for Longitude Capital where he focused on investments in medical devices.

Rich Ferrari, myoscience executive chairman, added: “Jeff is a seasoned executive with a solid record of success. The myoscience board of directors fully supports the appointment and we are excited to have Jeff accept the leadership role as CEO.”

28th November 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....